       Document 0371
 DOCN  M9640371
 TI    U.S. prisoners' access to experimental HIV therapies.
 DT    9604
 AU    Collins A; Baumgartner D; Henry K; Minnesota Department of Corrections,
       USA.
 SO    Minn Med. 1995 Nov;78(11):45-8. Unique Identifier : AIDSLINE
       MED/96102653
 AB    PURPOSE: To examine Department of Corrections (DOC) policies prohibiting
       prisoner participation in research studies and to assess the variables
       associated with state policies and practices relating to access by
       inmates in U.S. prisons to HIV-related clinical studies and experimental
       therapies. METHODS: A telephone survey conducted in 1994-95 of DOC
       medical directors from 32 states throughout the United States to obtain
       information about state DOC policies and practices relating to HIV
       clinical studies. RESULTS: State policies governing prisoner
       participation in clinical trials and access to new therapies vary
       widely. States with high AIDS incidence rates, a large number of
       AIDS-related deaths in prison, and high concentrations of minorities in
       the correctional system were more likely to allow prisoners to enroll in
       clinical studies and to receive experimental medications. Overall, a
       relatively small number of prisoners in state prisons have enrolled in
       clinical studies. Participation of a prison representative on the board
       reviewing a clinical study was identified as an important factor in
       allowing prisoner participation in studies. CONCLUSIONS: Barriers to
       prisoner participation in clinical studies are numerous but not
       insurmountable. Results from this study have led to efforts in Minnesota
       to revise current policy in order to permit prisoner participation in
       studies if appropriate guidelines are followed.
 DE    Antiviral Agents/*THERAPEUTIC USE  Clinical Trials/*LEGISLATION &
       JURISPRUD  Health Policy/LEGISLATION & JURISPRUD  Health Services
       Accessibility/*LEGISLATION & JURISPRUD  Human  HIV Infections/*DRUG
       THERAPY  Prisoners/*LEGISLATION & JURISPRUD  United States  JOURNAL
       ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

